Cyberattack Cripples Major U.S. Health Care Network
Biomarkers + Patient-Reported Outcomes Up Prediction of Interstitial Cystitis
Area under the curve higher for biomarker measurements and patient-reported outcomes versus outcomes or biomarkers alone
Neoadjuvant Chemohormonal Therapy Aids Locally Advanced Prostate Cancer
Significant benefits in terms of three-year biochemical progression-free survival seen for NCHT versus neoadjuvant hormonal therapy
FDA Approves New Antibiotic for Uncomplicated Urinary Tract Infections
Approval of Pivya is for female adults with UTIs caused by susceptible isolates of E. coli, P. mirabilis, and S. saprophyticus
Multisite QI Collaborative Increases Appropriate Pediatric Antibiotic Use
Increase seen in median adherence to empirical, definitive, and duration of antibiotic therapy during intervention period
Cabozantinib Promising for Metastatic Pheochromocytomas, Paragangliomas
Overall response rate was 25.0 percent in phase 2 study involving 17 patients
Impaired Fecundity Rate in Women Unchanged From 2011 to 2019
However, infertility among married women ages 15 to 44 years rose
New Prostate Cancer Urine Test Has High Diagnostic Accuracy
Higher AUROC seen for 18-gene MPS2 model compared with current guideline-endorsed biomarkers
Hospital Mortality Lower for Patients Treated by Female Physicians
Benefit of receiving treatment from female physicians larger for female than male patients
Computer Prompts Could Reduce Empiric Antibiotic Use for UTI
17.4 percent reduction seen in empiric extended-spectrum days of therapy, with no increase in safety outcomes
